Johannes J. Kingma
President, Chief Executive Officer, Corporate Secretary and Director
Mr. Kingma is a self-employed businessman who has served as CEO of a private investment company (2006 – ) and President, Chairman, and a Director of Synstream Energy Corp. (TSX-V:SHM), since 2007. He has also served as director and officer of a number of private and public companies (2004 – 2010). Prior to this, Mr. Kingma was a Partner, sales manager and investment advisor with IPO Capital Corp., and was similarly a registered investment advisor with Canadian Western Capital Limited.
Vincent E. Ghazar
Chief Financial Officer and Director
Mr. Ghazar has served CFO and Director of Asia Cannabis Corp. from early 2018. Mr. Ghazar has a professional accounting practice (2014 – ), is the Controller of Synstream Energy Corp. (2013 – ), and CFO and VP Finance of Standard Exploration Ltd., both public companies. He has advance training in compliance, regulatory and governance practices and has extensive IFRS and GAAP experience.
Mr. Kovalchuk has served as an Asia Cannabis Corp. Director since mid 2018. He is the co-founder of Inplanta Biotechnolgy Inc. (est. 2015), founder of genomics company Plantbiosis ( est. 2010), and a (co)founder of Pathway Rx (est. 2016). Presently, he is a Professor and the Board of Governors Research Chair at the University of Lethbridge, Department of Biological Sciences (2001 – ) and Board of Governors’ Research Chair in Plant Biotechnology (2007 – ). He is also executive member and Scientific Leader of Alberta Epigenetics Network (2014 – ), and a Director of Next Generation Sequencing Facility (2010 – ).
David E.T. Pinkman
Mr. Pinkman has been CFO of International Softrock Oil Company Ltd., a TSX-V listed oil and gas company, since 2012. He also served as VP and Corporate Secretary at Red Rock Energy Inc. (2005-2017) and also served as its Interim CFO. Mr. Pinkman was CFO of Synstream Energy Corp., a TSX-V listed company (2007 to 2018) and was a director thereof from 2007 until the present.
Kenneth R. McKinnon, Q.C., ICD.D
Mr. McKinnon has been a Director of Asia Cannabis Corp. since October 2018. He has been a Partner at Citrus Capital Partners Ltd. (a consulting firm, since 2014). Mr. McKinnon has held roles with private and publicly-traded resource companies including Director and on Compensation and Audit Committees since 2006, was executive counsel with Critical Mass Inc. (a major media company), is Past President of the University of Calgary Alumni Association and recipient of the Order of University of Calgary, Haskayne School of Business (2014).
Dr. Darryl Hudson, P.H.D
Dr. Hudson is a principal of InPlanta Biotechnology Inc. and received a PhD in Molecular Biology and Genetics from the University of Guelph in 2010. He has published research in diverse fields including plant biology, genetics, epigenetics, DNA repair mechanisms, and carcinogenesis. He primarily works as a consultant and researcher helping producers in many countries to optimize genetics, cultivation processes and quality assurance protocols in the Cannabis industry. In addition to participating in a recently published Cannabis genome sequencing project, Dr. Hudson been breeding specialized new varieties of Cannabis for both the medical marijuana and agricultural hemp market and has been active in studying effects of Cannabis in treating post traumatic stress disorder specifically working with military veterans to develop both medications and protocols. Dr. Hudson has spoken before the US Senate Committee on Veteran Affairs prior to the institution of ground- breaking legislation that allowed US veterans to receive recommendations for medical marijuana treatment in states with legal Cannabis programs. He has acted as a judge at Cannabis competitions and continues to speak at many international conferences.